Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Beneish M-Score: -2.74 (As of Jun. 25, 2026)


BSP:PFRM3 Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
75 GF Score
Price R$6.42
GF Value R$8.00
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score?

Profarma Distribuidora De Produtos Farmaceuticos BSP:PFRM3 +4.22% 75 Beneish M-Score is -2.74 as of Jun. 25, 2026. GuruFocus rates BSP:PFRM3 with a GF Score™ of 75/100 and a GF Value™ of R$8.00 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 113 Medical Distribution companies, Profarma Distribuidora De Produtos Farmaceuticos ranks better than 70.8% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.74 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score or its related term are showing as below:

BSP:PFRM3' s Beneish M-Score Range Over the Past 10 Years
Min: -3.13   Med: -2.39   Max: -1.68
Current: -2.74

During the past 13 years, the highest Beneish M-Score of Profarma Distribuidora De Produtos Farmaceuticos was -1.68. The lowest was -3.13. And the median was -2.39.


Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.25 -1.82 -2.97 -2.72 -2.75

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.59 -2.63 -2.66 -2.75 -2.74

BSP:PFRM3 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score falls into.


BSP:PFRM3
75GF Score
Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Profarma Distribuidora De Produtos Farmaceuticos for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0426+0.528 * 0.9716+0.404 * 0.9887+0.892 * 1.0943+0.115 * 1.0175
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3859+4.679 * -0.064267-0.327 * 1.0076
=-2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was R$1,777 Mil.
Revenue was 2873.9 + 3187.975 + 2850.074 + 2701.974 = R$11,614 Mil.
Gross Profit was 434.404 + 475.284 + 447.028 + 433.979 = R$1,791 Mil.
Total Current Assets was R$4,266 Mil.
Total Assets was R$6,040 Mil.
Property, Plant and Equipment(Net PPE) was R$843 Mil.
Depreciation, Depletion and Amortization(DDA) was R$206 Mil.
Selling, General, & Admin. Expense(SGA) was R$989 Mil.
Total Current Liabilities was R$3,216 Mil.
Long-Term Debt & Capital Lease Obligation was R$1,057 Mil.
Net Income was -1.75 + 38.777 + 46.684 + 21.769 = R$105 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = R$0 Mil.
Cash Flow from Operations was 34.751 + 86.995 + 439.747 + -67.852 = R$494 Mil.
Total Receivables was R$1,557 Mil.
Revenue was 2710.498 + 3015.91 + 2604.215 + 2282.802 = R$10,613 Mil.
Gross Profit was 394.143 + 413.672 + 395.649 + 386.491 = R$1,590 Mil.
Total Current Assets was R$4,174 Mil.
Total Assets was R$5,788 Mil.
Property, Plant and Equipment(Net PPE) was R$711 Mil.
Depreciation, Depletion and Amortization(DDA) was R$177 Mil.
Selling, General, & Admin. Expense(SGA) was R$652 Mil.
Total Current Liabilities was R$3,252 Mil.
Long-Term Debt & Capital Lease Obligation was R$812 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1776.673 / 11613.923) / (1557.223 / 10613.425)
=0.152978 / 0.146722
=1.0426

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1589.955 / 10613.425) / (1790.695 / 11613.923)
=0.149806 / 0.154185
=0.9716

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4265.688 + 842.583) / 6039.789) / (1 - (4174.34 + 710.88) / 5788.154)
=0.15423 / 0.155997
=0.9887

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=11613.923 / 10613.425
=1.0943

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(177.221 / (177.221 + 710.88)) / (205.565 / (205.565 + 842.583))
=0.199551 / 0.196122
=1.0175

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(988.683 / 11613.923) / (651.914 / 10613.425)
=0.085129 / 0.061424
=1.3859

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1057.486 + 3215.576) / 6039.789) / ((811.888 + 3252.37) / 5788.154)
=0.707485 / 0.702168
=1.0076

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(105.48 - 0 - 493.641) / 6039.789
=-0.064267

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Profarma Distribuidora De Produtos Farmaceuticos has a M-score of -2.74 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.74 mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a Beneish M-Score of -2.74 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #33 out of 113 companies in the Medical Distribution industry, placing it in the top 29.2%.
Is Profarma Distribuidora De Produtos Farmaceuticos' Beneish M-Score too high?
Profarma Distribuidora De Produtos Farmaceuticos' current Beneish M-Score is -2.74. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #33 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #33 out of 113 companies for Beneish M-Score. This puts Profarma Distribuidora De Produtos Farmaceuticos in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. Profarma Distribuidora De Produtos Farmaceuticos's current Beneish M-Score is -2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.00, compared to a current price of R$6.42 — trading 19.8% below its estimated fair value. The current Beneish M-Score is -2.74. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current Beneish M-Score is -2.74 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?

Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued. The current stock price of R$6.42 is trading 19.8% below its estimated GF Value™ of R$8.00. GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.

Key valuation signals for BSP:PFRM3:

  • Beneish M-Score: -2.74
  • GF Value™: R$8.00 vs. price of R$6.42 (19.8% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profarma Distribuidora De Produtos Farmaceuticos Business Description

Address Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score

Get the complete analysis for BSP:PFRM3

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.42
Price
R$8.00
GF Value